PTC Therapeutics has agreed to a licensing deal with Swiss pharmaceutical firm Roche for its spinal muscular atrophy program that could be worth as much as $490 million.Under the terms of the agreement, Roche gains an exclusive worldwide license to PTC’s SMA program, which includes three compounds currently in preclinical development, as well as potential [...]

Dr. Harsukh Parmar has rejoined Roche from AstraZeneca (NYSE:AZN) as the head of translational and experimental medicine for its inflammation discovery and translational area at its Nutley, New Jersey campus, according to a statement from the company.Parmar will be responsible for developing compounds to the life-cycle investment point. Additionally, he’ll also collaborate with discovery and [...]

AIDS drug company Trimeris (NASDAQ:TRMS) is getting $4.9 million from partner Roche (OTC:RHBBY) to settle a royalties dispute regarding the AIDS drug Fuzeon.Durham, North Carolina-based Trimeris and Swiss pharmaceutical giant Roche have clashed over Fuzeon royalty payments since 2009. Under a development and license agreement between the companies, Fuzeon is manufactured by Roche and distributed [...]